David Rosenblatt has a track record of developing and scaling businesses from startup through IPO in Silicon Valley, Wall Street and Israel.  David’s experience spans the technology, finance, energy and healthcare industries.  Previously, David served as Managing Director at Blackrock as well as a founder of Quickenloans at Intuit.   Prior to turning to business, David practiced corporate and international law with Chadbourne & Parke and Weil, Gotshal & Manges.  David currently sits on the boards of Dunn Meadow, Arava Power, Security Matters, LibertyTrax, American Technion Society, and serves as a sector lead for HBS Alumni Angels New York.  David holds an MBA with distinction from Harvard Business School, a JD from Northwestern University Law School, and a BS with honors from Pennsylvania State University. Zev Scherl has over 25 years of experience in a variety of executive management and investor positions in the pharmaceutical, healthcare services and information technology industries; including roles as General Partner, NewSpring Capital co-leading its healthcare investments from 2003 until 2013; Vice President, Venture Investments at Pequot Ventures; Vice President, Private Equity at Behrman Capital; Director, Strategic Planning at Value Health, Inc.; and Manager, U.S. Marketing at Merck & Co.  Zev is a seasoned executive with hands on experience building growth companies including his current role as President, Inception Companies. He currently sits on the board of directors of Inception Companies, Dunn Meadow Pharmacy, and LibertyTrax, as well as the Prix Galien Foundation. Zev received his MBA in 1990 from Harvard Business School and his BA in 1986 from Duke University.